People, power and planning in public places: the making of Covenant Day

Autor: Keith Henry, Greg Lloyd, Heather Ritchie

Publikováno v: Urban, Planning and Transport Research, Vol 3, Iss 1, Pp 109-131 (2015)

Cities have been heralded as the spatial manifestation of differentiated land uses and activities. The planning system has tried to establish some interpretation of sense for the public good within this paradoxical and contested place. There is no si

Externí odkaz: https://doaj.org/article/ff68d15bd4b541029f557aa0b9511a4e

Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial.

Autor: Jason V Baker, Kathleen Huppler Hullsiek, Rachel Prosser, Daniel Duprez, Richard Grimm, Russell P Tracy, Frank Rhame, Keith Henry, James D Neaton

Publikováno v: PLoS ONE, Vol 7, Iss 10, p e46894 (2012)

Treatments that reduce inflammation and cardiovascular disease (CVD) risk among individuals with HIV infection receiving effective antiretroviral therapy (ART) are needed.We conducted a 2 × 2 factorial feasibility study of lisinopril (L) (10 mg dail

Externí odkaz: https://doaj.org/article/a48e4844541248c78e0ce4f8eb569826

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Autor: Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry, David M Asmuth, David Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Stephanie Cox, Alexander Kintu, Christoph Carter, Moupali Das, Jared M Baeten, Diana M Brainard, Gary Whitlock, Jason M Brunetta, Gitte Kronborg, Christoph D Spinner, Andrea Antinori, Vanessa Apea, David Asmuth, Ann Avery, Paul Benson, Colm Bergin, Mezgebe Berhe, Indira Brar, Cynthia Brinson, Jason Brunetta, Jeffrey Burack, Thomas Campbell, Michelle Cespedes, Amanda Clarke, Megan Coleman, Josep Coll, Manuel Crespo Casal, Catherine Creticos, Gordon Crofoot, Frederick Cruickshank, Eric Cua, Eric Daar, Joseph de Wet, Edwin DeJesus, Jorge Del Romero Guerrero, William Dinges, Susanne Doblecki-Lewis, Taylor Donovan, Olamide Dosekun, Jason Flamm, Joel Gallant, Jan Gerstoft, Jay Gladstein, Robert Grant, Robert Grossberg, Bernhard Haas, Jason Halperin, W. David Hardy, Charles Hare, Shawn Hassler, Richard Hengel, William Henry, Theo Hodge, Sybil Hosek, Christopher Hurt, Michelle Iandiorio, Heiko Jessen, Stephen Kegg, Gabriele Knecht, Ivanka Krznaric, Anthony LaMarca, Carsten Schade Larsen, Olav Ditlevsen Larsen, Adriano Lazzarin, Clifford Leen, Christopher Lucasti, Patrick Mallon, Sharon Mannheimer, Martin Markowitz, Claudia Martorell, Kenneth Mayer, Anthony Mills, Jean-Michel Molina, Sheldon Morris, Karam Mounzer, Nneka Nwokolo, Olayemi Osiyemi, Andrew Petroll, Patrick Philibert, John Phoenix, Gilles Pialoux, Frank Post, Maria Prins, Moti Ramgopal, Bruce Rashbaum, Iain Reeves, Gary Richmond, Armin Rieger, Peter Ruane, Laura Salazar, Anthony Scarsella, Gabriel Schembri, Mia Scott, Peter Shalit, Gary Sinclair, Magdalena Sobieszczyk, Christoph Spinner, Jeffrey Stephens, Jason Szabo, Stephen Taylor, Melanie Thompson, Cecile Tremblay, Benoit Trottier, Gene Voskuhl, Barbara Wade, Kimberly Workowski, Sigal Yawetz, Benjamin Young

Publikováno v: The Lancet HIV, 8(7), e397-e407. Elsevier Limited
DISCOVER study team 2021, ' Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet HIV, vol. 8, no. 7, pp. e397-e407 . https://doi.org/10.1016/S2352-3018(21)00071-0

Summary Background In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303b5922ad83d78a448781b8c096428c
https://doi.org/10.1016/s2352-3018(21)00071-0

Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study

Autor: John T. Brooks, Pragna Patel, Lois Conley, Keith Henry, Elizabeth R. Unger, Gerome Escota, Teresa M. Darragh, Erna Milunka Kojic, Tim Bush

Publikováno v: The Journal of infectious diseases, vol 222, iss 2

BackgroundHigh-risk anal human papillomavirus (HPV) infection is prevalent among men living with human immunodeficiency virus (HIV); the association between 9-valent (9v) high-risk HPV (HR-HPV) vaccine types and abnormal cytology has not been well ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1643d0e2c6066524712ce61f4e9ba0ea
https://doi.org/10.1093/infdis/jiz425

Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences

Autor: Randy D. Blakely, Paul J. Gresch, Danielle Krout, L. Keith Henry, Rania M. Katamish, Meagan A. Quinlan, Matthew J. Robson, Catherine Nettesheim, Deborah C Mash

Publikováno v: ACS Chem Neurosci

The antidepressant-sensitive serotonin (5-HT) transporter (SERT) dictates rapid, high-affinity clearance of the neurotransmitter in both the brain and periphery. In a study of families with multiple individuals diagnosed with autism spectrum disorder

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::829173a2643ff7e2ccb72ffc1bafc7e0
https://doi.org/10.1021/acschemneuro.8b00689